Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Cardiome Pharma Corp T.COM

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  CRME

Cardiome Pharma Corp is a specialty pharmaceutical company. The Company is engaged in the development and commercialization of cardiovascular therapies that will improve the quality of life and health of patients suffering from heart disease.
Price: N/A | Change: N/A | %Change: N/A
Volume: N/A | Day High/Low: N/A/N/A | 52 Week High/Low: N/A/N/A
No data found for T.COM, the primary tickerSymbol is .
View modes: 
0 stars


I haveTRL,and PLI,and DND   .DND and PLI have  been the best for me but only after a long wait.Many years for DND as a matter of fact.  rate and reply
0 stars


NOT the only one , but after Merck left , i guess nobody believed in the C° anymore !  I hold all my shares (unless some unexpected bad things ) untill a decent MC or a BO ! more
0 stars


This stock is spectacular lately.But because its relatively expensive it weeds out the kids with their childish commentary.Makes for a lonely board.Am I the only one that has a small fortune in more
0 stars

Positive Data From Phase 3 Trial, Cardiome

Cardiome Pharma Corp. (COM.TO) Touts Positive Data From Phase 3 BRINAVESS® Trial Cardiome Announces Positive Results from the BRINAVESS® Asia-Pacific Phase 3 Clinical Trial more
0 stars

News to come on the 18th?

  rate and reply
0 stars

RE:Just Got Lucky This Time..

Noone is listening to you..or havent you noticed?This isnt one of your penny stocks.BTW do you ever read your own posts?  rate and reply
1 star

Just Got Lucky This Time..

sold all COM by luck to cover shortfall in trades elsewhere. Many pharmas. are dropping like a stone, not exactly pipeline and bank stocks here. So, put in your "sell on stops" frequently more
1 star

The Kind of '^Targets" We Like...

not the usual $1 or $1.30 left to the "upside" from current price. Canaccord Genuity has upgraded its then-target of $9.50 to a juicy $14.00 target. That's a neat 'n tidy 40% more
1 star

Uchuck's ETF for Cndn. Pharma?

see my note under T.CXR, Concordia Health Care.  rate and reply
0 stars

RE:Medicure and Cardiome

Good News   Cardiome $ 30 million cash so that is an assumption of Medicure increasingly likely. Medicure very good chance.  In 6 months the Medicure is share either $ 5 more
0 stars

Medicure and Cardiome

Medicure's shares are significantly undervalued. Price target Medicure $ 2.80!  The chart speaks for a very bullish trend of the outbreak of the shares is imminent.  Medicure more
0 stars

just never can tell

When it was announced they were going it on their own in march it dipped to 40 cents.I panicked and sold 15000 shares between 39 and 45 cents . Just want to cry now . Wish the best to everyone on more
0 stars

RE:Medicure and Cardiome .....

Very good News. Medicure BioTec TenBagger  rate and reply
0 stars

RE:Medicure and Cardiome .....  rate and reply
0 stars

Medicure and Cardiome .....

Medicure Market value very low 4.2 million CAD dollars.(Shares outstanding 12,100,000) Cardiome Market value 170 millon dollars.  rate and reply
0 stars

Big news

And the data further supports the data in patients that haven't undergone surgery. THE EXTENT OF THE PROBLEM The true incidence of postoperative atrial fibrillation (POAF) following more
1 star

Note to investox (greedy Gus)

This TKO speculation is not within your purview to do so, other than to just fatten your own portfolio,  rate and reply
0 stars

Takeover speculation ?

The time is ripe for the takeover of Medicure. Thus the Aggrastat distribution rights would be completely at Cardiome. Medicure should therefore receive a takeover bid.  rate and reply

Stockhouse would like your help. Please click here.